Skip to main content
NCBI home page
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1987 Apr;79(4):1078–1081. doi: 10.1172/JCI112921

Bromocriptine and low dose cyclosporine in the treatment of experimental autoimmune uveitis in the rat.

A G Palestine, C G Muellenberg-Coulombre, M K Kim, M C Gelato, R B Nussenblatt
PMCID: PMC424286  PMID: 3494043

Abstract

The immunologic effects of bromocriptine and low dose cyclosporine on experimental autoimmune uveitis (EAU) induced in Lewis rats by S-antigen immunization were studied. Rats treated with a sub-optimal dose (low dose) of cyclosporine (2 mg/kg per d), bromocriptine (1.8 mg/kg per d), or both drugs were compared with untreated rats in regard to the development of EAU, lymphocyte proliferative responses, and anti-S-antigen serum antibodies. Bromocriptine alone decreased the incidence of EAU only in female rats (P less than 0.01), did not effect the lymphocyte proliferative response, but did significantly decrease antibody titers in both males (P less than 0.004) and females (P less than 0.0005). Low dose cyclosporine also partially decreased the incidence of EAU in female rats, but did not decrease antibody titers or lymphocyte proliferative responses. Bromocriptine plus low-dose cyclosporine led to more marked decreases in the incidence of EAU and anti-S-antigen antibody titers as well as in the lymphocyte proliferative assay (P less than 0.01 for males, P less than 0.0005 for females). This study suggests that bromocriptine can enhance the immunosuppression of low dose cyclosporine.

Full text

PDF
1078

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Berczi I., Nagy E., Asa S. L., Kovacs K. Pituitary hormones and contact sensitivity in rats. Allergy. 1983 Jul;38(5):325–330. doi: 10.1111/j.1398-9995.1983.tb04126.x. [DOI] [PubMed] [Google Scholar]
  2. Berczi I., Nagy E., Asa S. L., Kovacs K. The influence of pituitary hormones on adjuvant arthritis. Arthritis Rheum. 1984 Jun;27(6):682–688. doi: 10.1002/art.1780270612. [DOI] [PubMed] [Google Scholar]
  3. Bunjes D., Hardt C., Röllinghoff M., Wagner H. Cyclosporin A mediates immunosuppression of primary cytotoxic T cell responses by impairing the release of interleukin 1 and interleukin 2. Eur J Immunol. 1981 Aug;11(8):657–661. doi: 10.1002/eji.1830110812. [DOI] [PubMed] [Google Scholar]
  4. Claman H. N. How corticosteroids work. J Allergy Clin Immunol. 1975 Mar;55(3):145–151. doi: 10.1016/0091-6749(75)90010-x. [DOI] [PubMed] [Google Scholar]
  5. Glick B. Interrelation of the avian immune and neuroendocrine systems. J Exp Zool. 1984 Dec;232(3):671–682. doi: 10.1002/jez.1402320336. [DOI] [PubMed] [Google Scholar]
  6. Grossman C. J. Regulation of the immune system by sex steroids. Endocr Rev. 1984 Summer;5(3):435–455. doi: 10.1210/edrv-5-3-435. [DOI] [PubMed] [Google Scholar]
  7. Hedner L. P., Bynke G. Endogenous iridocyclitis relieved during treatment with bromocriptine. Am J Ophthalmol. 1985 Oct 15;100(4):618–619. doi: 10.1016/0002-9394(85)90697-x. [DOI] [PubMed] [Google Scholar]
  8. Hiestand P. C., Mekler P., Nordmann R., Grieder A., Permmongkol C. Prolactin as a modulator of lymphocyte responsiveness provides a possible mechanism of action for cyclosporine. Proc Natl Acad Sci U S A. 1986 Apr;83(8):2599–2603. doi: 10.1073/pnas.83.8.2599. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Nagy E., Berczi I., Friesen H. G. Regulation of immunity in rats by lactogenic and growth hormones. Acta Endocrinol (Copenh) 1983 Mar;102(3):351–357. doi: 10.1530/acta.0.1020351. [DOI] [PubMed] [Google Scholar]
  10. Nagy E., Berczi I., Wren G. E., Asa S. L., Kovacs K. Immunomodulation by bromocriptine. Immunopharmacology. 1983 Oct;6(3):231–243. doi: 10.1016/0162-3109(83)90023-1. [DOI] [PubMed] [Google Scholar]
  11. Nussenblatt R. B., Dinning W. J., Fujikawa L. S., Chan C. C., Palestine A. G. Local cyclosporine therapy for experimental autoimmune uveitis in rats. Arch Ophthalmol. 1985 Oct;103(10):1559–1562. doi: 10.1001/archopht.1985.01050100135035. [DOI] [PubMed] [Google Scholar]
  12. Nussenblatt R. B., Rodrigues M. M., Wacker W. B., Cevario S. J., Salinas-Carmona M. C., Gery I. Cyclosporin a. Inhibition of experimental autoimmune uveitis in Lewis rats. J Clin Invest. 1981 Apr;67(4):1228–1231. doi: 10.1172/JCI110138. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Palestine A. G., Austin H. A., 3rd, Balow J. E., Antonovych T. T., Sabnis S. G., Preuss H. G., Nussenblatt R. B. Renal histopathologic alterations in patients treated with cyclosporine for uveitis. N Engl J Med. 1986 May 15;314(20):1293–1298. doi: 10.1056/NEJM198605153142005. [DOI] [PubMed] [Google Scholar]
  14. Russell D. H., Kibler R., Matrisian L., Larson D. F., Poulos B., Magun B. E. Prolactin receptors on human T and B lymphocytes: antagonism of prolactin binding by cyclosporine. J Immunol. 1985 May;134(5):3027–3031. [PubMed] [Google Scholar]
  15. Russell D. H., Larson D. F., Cardon S. B., Copeland J. G. Cyclosporine inhibits prolactin induction of ornithine decarboxylase in rat tissues. Mol Cell Endocrinol. 1984 May;35(2-3):159–166. doi: 10.1016/0303-7207(84)90012-1. [DOI] [PubMed] [Google Scholar]
  16. Russell D. H., Larson D. F. Prolactin-induced polyamine biosynthesis in spleen and thymus: specific inhibition by cyclosporine. Immunopharmacology. 1985 Jun;9(3):165–174. doi: 10.1016/0162-3109(85)90012-8. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES